​

• October 15, 2021: Dr. Keyak and associates submit a research article to the peer-reviewed journal Physics in Medicine and Biology, the official journal of the International Organization for Medical Physics, titled "A Preliminary Safety Assessment of Vertebral Augmentation with 32P Brachytherapy Bone Cement", an animal study showing safety in sheep.

• February 13, 2021: Dr. Keyak and associates present a research paper to the Orthopedic Research Society titled: "Preliminary Safety Assessment of Kyphoplasty with Brachytherapy Bone Cement in an Ovine Model." Trans Orthop Res Soc 46: 1688-LB, 2021.

• April 30, 2019: Patent No. 10,272,173, “Radioactive Bone Cement”, issued and licensed to Bone-Rad Therapeutics, Inc.

• June 2017: Prof. Keyak procures a UCI Dept of Radiological Science Seed Grant for an in vivo study of Radioactive Bone Cement in sheep. 2017-2022.

• May 1, 2017: Bone-Rad Therapeutics is featured in the Orange County Business Journal.

• March 2017: Prof. Joyce Keyak, discussing Bone-Rad Therapeutics, is featured in Cove Currents, a UCI applied innovation journal.

• March 21, 2017: Patent No. 9,597,427, “Radioactive Bone Cement”, issued and licensed to Bone-Rad Therapeutics, Inc.

• December 1, 2015: Patent No. 9,198,989, “Radioactive Bone Cement”, issued and licensed to Bone-Rad Therapeutics, Inc.

• May 12, 2015: Patent No. 9,028,499, “Bone Cutting Device”, issued and licensed to Bone-Rad Therapeutics, Inc.

• June 16,2014: The Innovation Institute LLC (a research arm of the St Joseph Health System) and Bone-Rad Therapeutics, Inc. sign a memorandum of agreement to work together on advancing the use of radioactive cement for treatment of metastatic lesions.

• June 16, 2012: Drs. Kaneko, Keyak, Sehgal, and Skinner co-author a research article, entitled "Radioactive bone cement for the treatment of spinal metastases: a dosimetric analysis of clinical scenarios", in the peer-reviewed journal Physics in Medicine and Biology, the official journal of the International Organization for Medical Physics.

• ​May 26, 2011: Orange County Register: "What is O.C.'s next business superstar?"

• ​May 24, 2011: Bone-Rad Therapeutics is selected as one of twelve start-up companies to participate in the Investment Presentations at OCTANe's VC in the OC event, to be held at the Hyatt Regency in Irvine, CA. Additionally, please visit us during the event's OC Innovation Company Showcase.

• ​May 17, 2011: Orange County Register: "'Real Housewives' mixing with venture capitalists"

• April 6, 2011: Dr. Marquez M, with Kaneko TS, Keyak JH present a research paper at the 21st Interdisciplinary Research Conference on Injectable Osteoarticular Biomaterials and Augmentation Procedures: A novel device for creating a void during vertebroplasty for bone metastases.  Boston, MA.

• April 5,2011: Dr. Kaneko, with Sehgal V, Skinner HB, Al-Ghazi MSAL, Hoang BH, Ramsinghani NS, Keyak JH, present a research paper at the 21st Interdisciplinary Research Conference on Injectable Osteoarticular Biomaterials and Augmentation Procedures: Radioactive Bone Cement for the Treatment of Vertebral Metastases. Boston MA.

• February 8, 2011: Bone-Rad Therapeutics invited to present at the Medical Technology Innovation Summit, to be held at the Medical Device & Manufacturing (MD&M) West Exposition and Conference in Anaheim, CA.

• October 21, 2010: Bone-Rad Therapeutics has named Steve Naber as its new President and CEO. Mr. Naber has been involved with the financing and operations of start-up medical device companies for the past 20 years. Dr. Harry Skinner, the former President and CEO, will now serve as Bone-Rad's Chairman.

• May 13, 2010: The research article published in Physics in Medicine and Biology is selected as a Featured Article and an Editor's Choice for the journal, and is profiled on MedicalPhysicsWeb in an article entitled "Model predicts dose from radioactive cement".

• April 26, 2010: Bone-Rad Therapeutics, Inc. and The University of California have signed a license agreement, giving Bone-Rad Therapeutics exclusive commercial rights to the radioactive bone cement technology being developed in Dr. Keyak's lab.

• April 7, 2010: Drs. Kaneko, Keyak, Sehgal, and Skinner co-author a research article, entitled "Evaluation of a radiation transport modeling method for radioactive bone cement", in the peer-reviewed journal Physics in Medicine and Biology, the official journal of the International Organization for Medical Physics.

• January 14, 2010: The research behind radioactive bone cement, performed in Dr. Keyak's lab at UC Irvine, is featured as a Research Highlight by the Department of Defense (DOD) Congressionally Directed Medical Research Program.

• September 10, 2009: Orange County Register: "What Is Radioactive Bone Cement?"

• September 7, 2009: Dr. Keyak is named 10th on a list of the 25 Most Influential in Radiology, by RT-Image.

• February 13, 2009: Orthopaedic Research Society issues press release: "Breast Cancer Patients May Have a New Treatment Option When Cancer Spreads"

• December 1, 2008: Dr. Keyak is profiled by Today@UCI for her groundbreaking work in orthopaedic research, including the development of radioactive bone cement.

• September 19, 2008: Please join Bone-Rad Therapeutics, Inc. at the 10th SoCalBio Investor Conference at the Wilshire Grand Hotel in Los Angeles, California

• June 5, 2008: Bone-Rad Therapeutics, Inc. is an exhibitor at BIOCOM DeviceFest 2008 in Costa Mesa, California

• March 7, 2008: Bone-Rad Therapeutics, Inc. presents to the Board of Directors of the Don Beall Center for Innovation and Entrepreneurship at the University of California, Irvine

• November 15, 2007: Bone-Rad Therapeutics, Inc. presents at the 2nd OCTANe California Medical Device Forum, in Costa Mesa, California

• August 2, 2007: Bone-Rad Therapeutics, Inc. finalizes a letter agreement with the University of California, obtaining exclusive rights to license the patent for radioactive bone cement

• June 19, 2007: Bone-Rad Therapeutics is certified as a C Corporation in the state of Delaware

• June 12, 2007: Bone-Rad Therapeutics finalizes an engagement letter with Stradling Yocca Carlson & Rauth, Attorneys at Law, to provide legal counsel and representation

• June 2007: Bone-Rad Therapeutics wins the UC Irvine Stradling Yocca Carlson and Rauth Business Plan Competition (University of California, Irvine, Paul Merage School of Business Alumni Newsletter)

• May 18, 2007: Orange County Register: "Bone cancer treatment wins UCI business plan contest"

• May 11, 2007: Bone-Rad Therapeutics competes in the Orange County Register's People's Choice Award contest

• May 11, 2007: Watch the Bone-Rad Therapeutics elevator pitch